November 2023
1. BUENO L, Bermejo A, Gascon M, Gimenez-Palomo A, et al
   Pramipexole as an Augmentation Strategy to Electroconvulsive Therapy in the Treatment of Bipolar Depression Complicated With Parkinsonism: A Case Report.
   J Clin Psychopharmacol. 2023;43:543-546.
   

   >> Share

   
   October 2023
2. BUENO L, Bermejo A, Gascon M, Gimenez-Palomo A, et al
   Pramipexole as an Augmentation Strategy to Electroconvulsive Therapy in the Treatment of Bipolar Depression Complicated With Parkinsonism: A Case Report.
   J Clin Psychopharmacol. 2023 Oct 12. doi: 10.1097/JCP.0000000000001761.
   

   >> Share

   
   September 2023
3. TKACH N, Opler DJ
   A Consideration for the Study of the Use of Cyproheptadine in Parkinson Disease Psychosis.
   J Clin Psychopharmacol. 2023;43:481-482.
   

   >> Share

   
   August 2023
4. TKACH N, Opler DJ
   Letter to the Editors: A Consideration for the Study of the Use of Cyproheptadine in Parkinson Disease Psychosis.
   J Clin Psychopharmacol. 2023 Aug 7. doi: 10.1097/JCP.0000000000001743.
   

   >> Share

   
   January 2023
5. COREKLI KAYMAKCI E, Kok Kendirlioglu B, Kucukgoncu S
   Parkinsonism Symptoms After Exposure to Low-Dose Aripiprazole.
   J Clin Psychopharmacol. 2023;43:69-70.
   

   >> Share

   
   February 2022
6. AL-QASSABI A, Al Sinani A
   Dopamine Dysregulation Syndrome in Parkinson Disease and Remission After Treatment With Aripiprazole.
   J Clin Psychopharmacol. 2022 Feb 7. pii: 00004714-900000000-98209.
   

   >> Share

   
   January 2022
7. CINTRON PASTRANA MA, Quintana Aviles E
   Treatment of Refractory Schizophrenia With Clozapine in a Patient With Wolff-Parkinson-White Syndrome.
   J Clin Psychopharmacol. 2022;42:95-96.
   

   >> Share

   
   

Free Medical Abstracts
Privacy Policy
Sponsors
Share